For which condition is Nebivolol primarily indicated?

Nebivolol is primarily indicated for the treatment of hypertension. As a selective beta-1 adrenergic antagonist, it works by blocking the effects of adrenaline on the heart, leading to decreased heart rate and reduced force of contraction. This results in lowered blood pressure, making it an effective antihypertensive medication. In addition to its cardioprotective effects, Nebivolol also has vasodilatory properties attributed to its ability to increase the availability of nitric oxide, which further contributes to its effectiveness in managing hypertension.

While Nebivolol may have some benefits in heart failure management due to its cardiac effects, its main indication remains hypertension. It is not primarily used for arrhythmias or coronary artery disease, as other medications or therapeutic strategies are typically preferred for those conditions. Thus, the focus on hypertension underscores the role of Nebivolol in clinical practice as a valuable option for managing elevated blood pressure.